Evidence map›Paper›PMID 25254655›Full record

SynthesisPLoS neglected tropical diseases2014

Strongyloides stercoralis: systematic review of barriers to controlling strongyloidiasis for Australian indigenous communities.

Adrian Miller, Michelle L Smith, Jenni A Judd, Rick Speare

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in PLoS neglected tropical diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Is strongyloidiasis a zoonosis from dogs?Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Review
  5. The Association between Diabetes and Human T-Cell Leukaemia Virus Type-1 (HTLV-1) withInternational journal of environmental research and public health · 2022
    Article
  6. Article
  7. Paediatric Strongyloidiasis in Central Australia.Tropical medicine and infectious disease · 2018
    Article
  8. Review
  9. A Community-Directed IntegratedTropical medicine and infectious disease · 2018
    Review
  10. Article
  11. Short communication: Epidemiological assessment ofParasite epidemiology and control · 2016
    Article
  12. Observational
  13. BioMed research international · 2016
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Adrian MillerIndigenous Research Unit, Griffith University, Brisbane, Australia.
Michelle L SmithIndigenous Research Unit, Griffith University, Brisbane, Australia.
Jenni A JuddFaculty of Medicine, Health and Molecular Sciences, James Cook University, Townsville, Queensland, Australia.
Rick SpearePublic Health and Tropical Medicine, James Cook University, Townsville, Queensland, Australia; Tropical Health Solutions Pty Ltd, Townsville, Queensland, Australia.
Griffith University · AUJames Cook University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStrongyloides stercoralis infects human hosts mainly through skin contact with contaminated soil. The result is strongyloidiasis, a parasitic disease, with a unique cycle of auto-infection causing a variety of symptoms and signs, with possible fatality from hyper-infection. Australian Indigenous community members, often living in rural and remote settings, are exposed to and infected with S. stercoralis. The aim of this review is to determine barriers to control of strongyloidiasis. The purpose is to contribute to the development of initiatives for prevention, early detection and effective treatment of strongyloidiasis. METHODOLOGY/PRINCIPLE

findingsSystematic search reviewing research published 2012 and earlier was conducted. Research articles discussing aspects of strongyloidiasis, context of infection and overall health in Indigenous Australians were reviewed. Based on the PRISMA statement, the systematic search of health databases, Academic Search Premier, Informit, Medline, PubMed, AMED, CINAHL, Health Source Nursing and Academic was conducted. Key search terms included strongyloidiasis, Indigenous, Australia, health, and community. 340 articles were retrieved with 16 original research articles published between 1969 and 2006 meeting criteria. Review found barriers to control defined across three key themes, (1) health status, (2) socioeconomic status, and (3) health care literacy and procedures. CONCLUSIONS/SIGNIFICANCE: This study identifies five points of intervention: (1) develop reporting protocols between health care system and communities; (2) test all Indigenous Australian patients, immunocompromised patients and those exposed to areas with S. stercoralis; (3) health professionals require detailed information on strongyloidiasis and potential for exposure to Indigenous Australian people; (4) to establish testing and treatment initiatives within communities; and (5) to measure and report prevalence rates specific to communities and to act with initiatives based on these results. By defining barriers to control of strongyloidiasis in Australian Indigenous people, improved outcomes of prevention, treatment of strongyloidiasis and increased health overall are attainable.

Indexed as

AdolescentAdultAnimalsAustraliaAustralian Aboriginal and Torres Strait Islander PeoplesChildChild, PreschoolFemaleHumansInfantInfant, NewbornMaleMiddle AgedRural PopulationStrongyloides stercoralisStrongyloidiasis

Identifiers

PMID25254655
PMCPMC4177786
OpenAlexW2048538555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.